| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |